Rehmann Capital Advisory Group’s SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $427K | Sell |
|
|||||
|
2025
Q1 | $429K | Hold |
|
|||||
|
2024
Q4 | $477K | Buy |
|
|||||
|
2024
Q3 | $489K | Hold |
|
|||||
|
2024
Q2 | $459K | Buy |
|
|||||
|
2024
Q1 | $246K | Buy |
|
|||||
|
2021
Q4 | – | Sell |
|
|||||
|
2021
Q3 | $277K | Hold |
|
|||||
|
2021
Q2 | $299K | Buy |
|
|||||
|
2021
Q1 | $261K | Buy |
|
|||||
|
2019
Q3 | – | Sell |
|
|||||
|
2019
Q2 | $81.5K | Sell |
|
|||||
|
2019
Q1 | $85.3K | Sell |
|
|||||
|
2018
Q4 | $2.8M | Buy |
|
|||||
|
2018
Q3 | $138K | Buy |
|
|||||
|
2018
Q2 | $103K | Buy |
|
|||||
|
2018
Q1 | $68K | Buy |
|